Home > Cancer and Treatments > Thoracic Cancer Program

Esophageal Cancer / Cancer of the Esophagus

There is hope, innovation and support available for those with esophageal cancer here at the U-M Comprehensive Cancer Center.

Jerry Poisson describes his experience with the U-M Comprehensive Cancer Center's Esophageal Cancer Program

About Esophageal Cancer
Esophageal cancer is a tumor or abnormal growth of cells in the esophagus. The esophagus is the tube that takes food from your mouth to your stomach. It is made of muscle and it is about 10 inches long.

The two most common forms of esophageal cancer are named for the type of cells that become cancerous:

  • Squamous cell carcinoma: Cancer that forms in squamous cells, the thin, flat cells lining the esophagus. This cancer is most often found in the upper and middle part of the esophagus, but can occur anywhere along the esophagus.
  • Adenocarcinoma: Cancer that begins in glandular (secretory) cells. Glandular cells in the lining of the esophagus produce and release fluids such as mucus. Adenocarcinomas usually form in the lower part of the esophagus, near the stomach.

Learn more about esophageal cancer in the Health Library, part of the UofMHealth.org website.

Less-Invasive Surgery for Cancer of the Esophagus

For patients with esophageal cancer, transhiatal esophagectomy without thoracotomy (removing the esophagus without opening the chest) was pioneered and refined at the University of Michigan by Mark Orringer, M.D. More than 2,000 patients have undergone this operation at the University of Michigan in the past 30 years, giving U-M physicians the most experience with this procedure in the United States.

The operative mortality rate for this procedure at U-M is less than 3%, with an average hospital stay of only seven days. The Thoracic Oncology Program is also a leader in the development of combined modality therapy for esophageal cancer, a therapy in which patients are treated with chemotherapy, radiotherapy and surgery in an attempt to improve their chances for survival.

Research and Innovation:
The U-M Thoracic Oncology Program has a variety of clinical trials available, ranging from chemoprevention studies to the evaluation of state-of-the-art investigational therapies. The team's expertise with emerging technologies, including:

  • stereotactic radiosurgery
  • radiofrequnecy ablation
  • photodynamic therapy
  • esophageal and airway stenting
  • ultrasound-guided transbronchial/transesophageal biopsy
  • video-assisted thoracoscopy
allows for less invasive options in the diagnosis and care of patients with thoracic cancers.

Support:
Since our program is part of the U-M Comprehensive Cancer Center, our patients have access to Patient/Family Support Services. To fully understand what this means, please take time to visit the For Cancer Center Patients area of this website. We outline the services available to our patients at every point in their care.

Make an appointment/referral to the Multidisciplinary Thoracic Cancer Clinic

To make a first time appointment, please call the Patient Care Center at 877-308-9111 (Monday-Friday, 8am-5:30pm EST). If you would like to refer a patient, please contact our M-Line service: 800-962-3555. For more information, visit our Appointments web page.

Still have questions?

The nurses at Cancer AnswerLine™ have answers. Call 1-800-865-1125 and you'll get a personal response from one of our registered nurses, who have years of experience in caring for people with cancer.

back to top

updated 06/2012


Small Text SizeMedium Text SizeLarge Text Size
Adjust text size

Speak with a Cancer nurse: 1-800-865-1125
make a donation
See Also
Clinical trials -on UMClinicalStudies.org